|
|
||||||||
The Journal of Immunology, Vol 146, Issue 2 749-755, Copyright © 1991 by American Association of Immunologists
ARTICLES |
T Collen, R Dimarchi and TR Doel
Vaccine Research Department, AFRC Institute for Animal Health, Pirbright, Surrey, England.
Synthetic peptides representing regions of the VP1 protein of foot-and- mouth disease virus strain 01 Kaufbeuren were screened for their ability to stimulate proliferation of PBMC from virus vaccinated cattle. Sites were identified at residue 21-40 (peptide FMDV32) and in the region C-terminal to residue 161. Cells responding to FMDV32 were MHC class II-restricted, CD4+ and secreted IL-2. Thus, this region is defined as a Th site. Of 19 virus vaccinated Friesian cattle, 89% (17/19) responded to purified virus while 37% (7/19; 41% of virus responders) also responded to FMDV32 suggesting that this site is immunodominant for the cattle used. Furthermore, immunisation of FMDV32 responder and non-responder cattle with a related peptide, FMDV5 (FMDV32 co-linearly synthesized with the 141-160 VP1 B cell site), induced neutralizing antibody and a virus-specific T cell population in the FMDV32-responder but not the non-responder animals.
This article has been cited by other articles:
![]() |
C. Cubillos, B. G. de la Torre, A. Jakab, G. Clementi, E. Borras, J. Barcena, D. Andreu, F. Sobrino, and E. Blanco Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric Peptide J. Virol., July 15, 2008; 82(14): 7223 - 7230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xiao, Z. I. Rajput, D. Liu, and S. Hu Enhancement of Serological Immune Responses to Foot-and-Mouth Disease Vaccine by a Supplement Made of Extract of Cochinchina Momordica Seeds Clin. Vaccine Immunol., December 1, 2007; 14(12): 1634 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-J. Hohlich, K.-H. Wiesmuller, B. Haas, W. Gerner, R. Correa, H.-R. Hehnen, T. Schlapp, E. Pfaff, and A. Saalmuller Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes J. Gen. Virol., December 1, 2003; 84(12): 3315 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tami, O. Taboga, A. Berinstein, J. I. Nunez, E. L. Palma, E. Domingo, F. Sobrino, and E. Carrillo Evidence of the Coevolution of Antigenicity and Host Cell Tropism of Foot-and-Mouth Disease Virus In Vivo J. Virol., December 20, 2002; 77(2): 1219 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Armengol, K.-H. Wiesmuller, D. Wienhold, M. Buttner, E. Pfaff, G. Jung, and A. Saalmuller Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus J. Gen. Virol., March 1, 2002; 83(3): 551 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Blanco, M. Garcia-Briones, A. Sanz-Parra, P. Gomes, E. De Oliveira, M. L. Valero, D. Andreu, V. Ley, and F. Sobrino Identification of T-Cell Epitopes in Nonstructural Proteins of Foot-and-Mouth Disease Virus J. Virol., April 1, 2001; 75(7): 3164 - 3174. [Abstract] [Full Text] |
||||
![]() |
E. Blanco, K. McCullough, A. Summerfield, J. Fiorini, D. Andreu, C. Chiva, E. Borrás, P. Barnett, and F. Sobrino Interspecies Major Histocompatibility Complex-Restricted Th Cell Epitope on Foot-and-Mouth Disease Virus Capsid Protein VP4 J. Virol., May 15, 2000; 74(10): 4902 - 4907. [Abstract] [Full Text] |
||||
![]() |
J. Chinsangaram, C. Beard, P. W. Mason, M. K. Zellner, G. Ward, and M. J. Grubman Antibody Response in Mice Inoculated with DNA Expressing Foot-and-Mouth Disease Virus Capsid Proteins J. Virol., May 1, 1998; 72(5): 4454 - 4457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |